BRPI1013548A2 - método de purificação industrial de ficotoxinas biologicamente ativas - Google Patents
método de purificação industrial de ficotoxinas biologicamente ativasInfo
- Publication number
- BRPI1013548A2 BRPI1013548A2 BRPI1013548A BRPI1013548A BRPI1013548A2 BR PI1013548 A2 BRPI1013548 A2 BR PI1013548A2 BR PI1013548 A BRPI1013548 A BR PI1013548A BR PI1013548 A BRPI1013548 A BR PI1013548A BR PI1013548 A2 BRPI1013548 A2 BR PI1013548A2
- Authority
- BR
- Brazil
- Prior art keywords
- biologically active
- purification method
- industrial purification
- phytotoxins
- active phytotoxins
- Prior art date
Links
- 238000000034 method Methods 0.000 title 1
- 229930000184 phytotoxin Natural products 0.000 title 1
- 238000000746 purification Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
- B01D15/08—Selective adsorption, e.g. chromatography
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/16—Peri-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Cephalosporin Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CL2009000723A CL2009000723A1 (es) | 2009-03-24 | 2009-03-24 | Metodo de purificacion industrial de ficotoxinas biologicamente activas que comprende proporcionar una cantidad adecuada de una fuente de ficotoxinas como por ejemplo el cultivo de un clon de cianobacterias. |
| PCT/IB2010/051187 WO2010109386A1 (es) | 2009-03-24 | 2010-03-18 | Método de purificación industrial de ficotoxinas biológicamente activas |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BRPI1013548A2 true BRPI1013548A2 (pt) | 2016-09-20 |
| BRPI1013548B1 BRPI1013548B1 (pt) | 2020-06-09 |
| BRPI1013548B8 BRPI1013548B8 (pt) | 2021-05-25 |
Family
ID=42780210
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI1013548A BRPI1013548B8 (pt) | 2009-03-24 | 2010-03-18 | método de purificação industrial de ficotoxinas biologicamente ativas |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP2412714B9 (pt) |
| JP (1) | JP5728774B2 (pt) |
| KR (1) | KR20110130420A (pt) |
| AR (1) | AR075931A1 (pt) |
| BR (1) | BRPI1013548B8 (pt) |
| CA (1) | CA2754154C (pt) |
| CL (1) | CL2009000723A1 (pt) |
| DK (1) | DK2412714T5 (pt) |
| ES (1) | ES2562637T3 (pt) |
| HR (1) | HRP20160079T1 (pt) |
| HU (1) | HUE027480T2 (pt) |
| MX (1) | MX2011010005A (pt) |
| PE (1) | PE20110903A1 (pt) |
| WO (1) | WO2010109386A1 (pt) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8952152B2 (en) | 2009-03-24 | 2015-02-10 | Proteus S.A. | Methods for purifying phycotoxins, pharmaceutical compositions containing purified phycotoxins, and methods of use thereof |
| WO2014145580A1 (en) | 2013-03-15 | 2014-09-18 | The Children's Medical Center Corporation | Neosaxitoxin combination formulations for prolonged local anesthesia |
| US9902625B2 (en) | 2014-09-03 | 2018-02-27 | International Business Machines Corporation | Removal of HAB-produced toxins from bodies of water |
| GB201602576D0 (en) | 2016-02-12 | 2016-03-30 | Bergen Teknologioverforing As | Process |
| CN107602580B (zh) * | 2017-09-08 | 2019-06-11 | 浙江理工大学 | 一种聚酮类化合物及其制备方法和应用 |
| CN109142595A (zh) * | 2018-08-23 | 2019-01-04 | 中国水产科学研究院黄海水产研究所 | 一种麻痹性贝类毒素标准溶液的制备方法 |
| CN117964629A (zh) * | 2018-09-21 | 2024-05-03 | 考思隆研究所托管委员会 | 将膝沟藻毒素制备性规模转化为新石房蛤毒素 |
| US12018034B2 (en) | 2018-09-21 | 2024-06-25 | The Cawthron Institute Trust Board | Semisynthetic methods of preparing GTX1,4 and neosaxitoxin |
| CA3113727A1 (en) * | 2018-09-21 | 2020-03-26 | The Cawthron Institute Trust Board | A semisynthetic method of preparing neosaxitoxin |
| CN114657222A (zh) * | 2022-04-08 | 2022-06-24 | 湖北省水利水电科学研究院 | 一种从水华束丝藻中提取类菌胞素氨基酸的方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001413A (en) | 1973-06-12 | 1977-01-04 | Astra Pharmaceutical Products, Inc. | Pharmaceutical local anesthetic composition employing saxitoxin |
| WO1998043619A2 (en) * | 1997-04-02 | 1998-10-08 | The Regents Of The University Of California | Method of local anesthesia |
| CN1585642A (zh) * | 2001-11-15 | 2005-02-23 | 微观藻类公司 | 包含3,4-丙炔基全氢化嘌呤的药物组合物及其在阻滞神经元传递方面的应用 |
| AU2005244105B2 (en) * | 2004-05-07 | 2011-10-06 | Algenis Spa | Phycotoxins and uses thereof |
| DE102006028817A1 (de) * | 2006-06-21 | 2007-12-27 | Evonik Degussa Gmbh | Aufarbeitung von Reaktionslösungen aus Ganzzell-Biotransformationen |
-
2009
- 2009-03-24 CL CL2009000723A patent/CL2009000723A1/es unknown
-
2010
- 2010-03-18 MX MX2011010005A patent/MX2011010005A/es active IP Right Grant
- 2010-03-18 ES ES10755518.7T patent/ES2562637T3/es active Active
- 2010-03-18 PE PE2011001285A patent/PE20110903A1/es active IP Right Grant
- 2010-03-18 HU HUE10755518A patent/HUE027480T2/en unknown
- 2010-03-18 DK DK10755518.7T patent/DK2412714T5/en active
- 2010-03-18 HR HRP20160079TT patent/HRP20160079T1/hr unknown
- 2010-03-18 KR KR1020117021288A patent/KR20110130420A/ko not_active Ceased
- 2010-03-18 BR BRPI1013548A patent/BRPI1013548B8/pt active IP Right Grant
- 2010-03-18 CA CA2754154A patent/CA2754154C/en active Active
- 2010-03-18 JP JP2012501444A patent/JP5728774B2/ja active Active
- 2010-03-18 EP EP10755518.7A patent/EP2412714B9/en active Active
- 2010-03-18 WO PCT/IB2010/051187 patent/WO2010109386A1/es not_active Ceased
- 2010-03-23 AR ARP100100934A patent/AR075931A1/es active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| CA2754154A1 (en) | 2010-09-30 |
| KR20110130420A (ko) | 2011-12-05 |
| EP2412714B9 (en) | 2016-11-23 |
| DK2412714T3 (en) | 2016-02-01 |
| HUE027480T2 (en) | 2016-09-28 |
| BRPI1013548B1 (pt) | 2020-06-09 |
| EP2412714B1 (en) | 2015-11-11 |
| CL2009000723A1 (es) | 2009-06-19 |
| ES2562637T9 (es) | 2017-05-30 |
| HRP20160079T1 (hr) | 2016-04-08 |
| DK2412714T5 (en) | 2017-02-27 |
| ES2562637T3 (es) | 2016-03-07 |
| MX2011010005A (es) | 2011-10-10 |
| WO2010109386A1 (es) | 2010-09-30 |
| CA2754154C (en) | 2013-12-17 |
| BRPI1013548B8 (pt) | 2021-05-25 |
| JP2012521408A (ja) | 2012-09-13 |
| EP2412714A4 (en) | 2012-10-10 |
| EP2412714A1 (en) | 2012-02-01 |
| AR075931A1 (es) | 2011-05-04 |
| JP5728774B2 (ja) | 2015-06-03 |
| PE20110903A1 (es) | 2012-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI1013548A2 (pt) | método de purificação industrial de ficotoxinas biologicamente ativas | |
| BRPI1009447A2 (pt) | métodos de purificação de proteínas imunofarmacêuticas modulares pequenas | |
| EP2485698A4 (en) | WHEELCHAIR SUSPENSION | |
| PL3056224T3 (pl) | Sposób sterylizacji | |
| EP2276795A4 (en) | Processing biomass | |
| BRPI1011061A2 (pt) | automacao de abatimento | |
| EP2226331A4 (en) | PROCESS FOR CLEANING PROTEINS | |
| PL2522724T3 (pl) | Sposób modyfikowania polipetydów do oczyszczania multimerów polipeptydowych | |
| BRPI1013538A2 (pt) | azetidinil diamidas como inibidores de monoacilglicerol lipase | |
| IL219715A (en) | Sewage treatment apparatus | |
| EP2509639A4 (en) | DISINFECTION SYSTEM FOR HARD SURFACES | |
| DK2477592T3 (da) | Rollatorkørestol | |
| BRPI1008300A2 (pt) | processo de purificação de daptomicina | |
| EP2391391A4 (en) | STERILIZATION PROCESS | |
| BRPI1011933A2 (pt) | composição de purificação de gás ácido | |
| EP2499255A4 (en) | EFFICIENT PRODUCTION OF PEPTIDES | |
| DK2598516T3 (da) | Fremgangsmåde til proteinoprensning | |
| PT2504298T (pt) | Preparação e purificação de iodoxanol | |
| BRPI0924579A2 (pt) | método de cultura de organismos fotossintéticos | |
| BRPI0915394A2 (pt) | purificação de citoquinas modificadas | |
| EP2405946A4 (en) | STERILIZATION PROCESS | |
| EP2352730A4 (en) | BIOLOGICAL ACTIVE AMIDE | |
| BR112012004676A2 (pt) | método de tratar infecções orotomixovirais. | |
| BRPI0922716A2 (pt) | purificação de polipeptídeo | |
| EP2519537A4 (en) | CLEANING PROTEINS |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B07E | Notice of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B06T | Formal requirements before examination [chapter 6.20 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 09/06/2020, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B16C | Correction of notification of the grant |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 18/03/2010 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |